SUMMARY The effects of daily subcutaneous administration of prostaglandin E1 (PGE,), theophylline, and of both drugs together were studied on the Freund's adjuvant-induced inflammatory and arthritic syndrome in rats. In the doses used, neither drug affected the acute inflammatory response in the adjuvant-treated paw, but together they caused marked inhibition. Chronic inflammation in the contralateral (nontreated) hind paws was slightly inhibited by each drug and combined treatment resulted in marked inhibition. The drugs also counteracted splenomegaly in adjuvantdiseased rats and their effects on spleen weight paralleled the inhibition of chronic inflammation. Arthritic lesions, as judged by x-rays of tibiotarsal joint destruction in the nontreated paws, were partially prevented by PGE1 alone, but not by theophylline. The combined treatment entirely prevented these joint lesions. PGE1 did not cause an increase in adrenal weight, but enhanced the effect of theophylline on adrenal weight. Only PGE1 improved gait in arthritic rats, simultaneous theophylline treatment having little additional effect.
Exogenously administered E-type prostaglandins (PGE) in high doses have been shown to suppress adjuvant-induced arthritis in rats (Aspinall and Cammarata, 1969; Zurier and Quagliata, 1971; Glenn and Rohloff, 1972; DiPasquale et al., 1973; Zurier et al., 1973) . In vitro, PGE increased the level of cyclic 3', 5'-adenosine monophosphate (cAMP) in leucocytes and this effect was associated with inhibited release of lysosomal enzymes from phagocytic cells (Scott, 1970; Weissmann, 1972; Weissmann et al., 1976; Lichtenstein et al., 1972) . It has been suggested that such a cAMP-mediated effect is one of the mechanisms underlying the anti-inflammatory effect of PGE on adjuvant arthritis (Zurier et al., 1973) . Evidence that PGE-induced elevation of leucocytic cAMP in vitro is enhanced by the simultaneous addition of the phosphodiesterase inhibitor, theophylline (Bourne et al., , 1974 , supports this.
We therefore decided to examine the influence of Accepted for publication September 5, 1977 Correspondence to Dr I. L. Bonta 212 PGE1 and theophylline in vivo on various parameters of adjuvant arthritis in rats. Some of our findings have been published (Bonta et al., 1977c tests.
Results
PGE l caused diarrhoea in several rats and approximately one hour after treatment some animals were slightly sedated. In the theophylline-treated animals piloerection and a somewhat increased respiration rate were observed. These effects were also noticeable in the animals receiving the combined treatment, but in every case were transient and the next day before receiving the drugs they displayed normal behaviour. Except for these general observations, no attempts were made to quantify the behaviour effects.
The 6-hour acute inflammation was not affected by either drug administered separately, but in the group receiving the combined drugs the increase in volume of the treated paw was markedly inhibited (Table 1) . Chronic inflammation of the untreated paw (increase in volume on day 28) was slightly inhibited by each of the drugs, combined treatment resulting in further inhibition (Table 1) . This marked inhibitory effect on the chronic inflammatory swelling following combined treatment is illustrated in Fig. 1 . The adjuvant control group showed gross malfunction of the untreated paw, which was apparent from the very low group score for gait of 6 (on the basis of the zero-hypothesis a similar nondiseased group of rats might have achieved a score of 24). Nearly maximal improvement in gait was seen in the rats treated with PGE1 only, whereas theophylline produced no significant improvement. Combined treatment resulted in virtually the same effect as PGE1 alone. These results are shown in Table 2 . Evaluation of x-rays of the tibiotarsal joints is also presented in Table 2 . Gross destruction of the joints of the untreated paws was observed in 5 out of 6 rats in the adjuvant control group. Theophylline alone failed to produce any significant improvement. Theoyhylline and PGE1 in adjuvant-induced arthritis 215 However, only 2 out of 6 PGE 1-treated rats had noticeably damaged joints. The protective action of PGE1 was further increased by simultaneous administration of theophylline. In this latter group, in fact, no tibiotarsal joint lesions were detectable. Body weights and various organ weights are given in Table 3 . Theophylline alone caused slight loss of body weight, but the initial and 35-day weights were not significantly different from the adjuvant controls in any of the other drug-treated groups. PGE1 alone did not increase adrenal weight, but markedly enhanced the slight increase caused by theophylline. (a) Splenomegaly was also apparent. In a separate experiment (data not included), the mean spleen weight of 6 rats treated with incomplete adjuvant, of the same age and weight, was 162 ± 2 mg. In contrast, the mean spleen weight of the adjuvant control rats was 247 ± 16 mg (Table 3 ). The increase in the weights of the spleens from adjuvant-diseased rats was counteracted equally by both drugs given separately and a further significant reduction in spleen weight occurred in animals receiving the drugs combined.
Discussion
Administration of Freund's complete adjuvant to the rat induces a complex inflammatory syndrome (Pearson, 1964) : acute inflammation in the injected paw and chronic inflammation and arthritic lesions (b) in the uninjected paw, between 10 and 14 days after group.bmj.com on June 25, 2017 -Published by http://ard.bmj.com/ Downloaded from (Weissmann et al., 1976) . Furthermore, PGE1 and the phosphodiesterase inhibitor, theophylline, act synergistically in raising intracellular cAMP and inhibiting lysosomal enzyme release from immune-sensitised cells in vitro (Bourne et al., , 1974 Lichtenstein et al., 1972) . In these studies the doses of PGE l were so large that the levels may have far exceeded those which probably occur under pathological conditions. Qualitatively, however, the synergism observed in this study between PGE1 and theophylline in inhibiting acute adjuvant-induced inflammation (injected paw), may be explained on the basis of cAMP-mediated inhibition of lysosomal enzyme release.
It has been suggested that PGE1 inhibits the chronic phase of adjuvant disease either by suppressing lymphocyte activation or by reducing the number of circulating lymphocytes (Zurier et al., 1973) . Recently, in vitro studies have shown that PGE-induced inhibition of T lymphocyte activation is correlated with increased intracellular cAMP levels Bourne et al., 1974; Morley, 1974; Gordon et al., 1976) . We have now found that theophylline and PGE1 each exerts a moderate suppressive effect on the chronic component of the adjuvant-syndrome. When combined, however, they exhibit an enhanced inhibitory effect, paralleled by inhibition of splenomegaly. It may be that in vivo PGE 1 and theophylline each enhances the chronic anti-inflammatory effect of the other by increasing cAMP levels in splenic and/or lymph node lymphocytes which might then result in reduced immunological activation and subsequent inhibition of the infiltration of circulating lymphocytes into the synovium. Parnham et al. (1977a) have shown that changes in cAMP levels in perfusates of noninjected arthritic rat paws correlate with the early, but not the later, stages of the chronic response. Thus, the major part of the mutual inhibitory activity of the two drugs on the chronic response was probably mediated by cAMP changes remote from the inflamed paw. As early as 1966, Ryzweski observed that cholinergic agents potentiated, whereas adrenergic agents inhibited, the chronic phase of adjuvant arthritis. Although no satisfactory explanation of these effects was possible at the time, it now appears, from in vitro studies, that cholinergic agents stimulate intracellular cGMP and adrenergic agents stimulate cAMP and that these cyclic nucleotides exert antagonistic effects on cellular function (Bourne et al., 1974; Weissmann et al., 1976) .
Although combined treatment with PGE1 and theophylline resulted in a marked increase in adrenal size, it is unlikely that release of endogenous corticosteroids accounted for the inhibitory effects observed. Firstly, PGE1 has been shown to suppress adjuvant disease in adrenalectomised animals (Zurier et al., 1973) . Secondly, in our investigation, the increase in adrenal weight did not appear to be correlated with other changes seen during chronic inflammation in rats treated with both PGE1 and theophylline. Thirdly, the anti-inflammatory, modulating role of endogenous corticosteroids during chronic inflammation in rats is, in fact, questionable (Parnham, 1977) . Fourthly, adjuvant disease itself is accompanied by a very high output of adrenal corticosteroids (Weissmann, 1972) and it is unlikely that any further PGE 1-and theophylline-induced increases would produce significant effects.
Inhibition of chronic inflammation was also accompanied by suppression of the arthritic lesions observed in the noninjected paw. The x-rays showed that PGE1 alone, and more particularly when administered with theophylline, almost completely counteracted the joint destruction. Although in vitro studies on cultured rat bone cells have shown that PGEs stimulate bone resorption (Klein and Raisz, 1970) , Morley (1974) has proposed that lymphokines (LKs) from sensitised lymphocytes stimulate macrophages to release PGs, which then inhibit further LK release and thus curtail the maintenance of the inflammatory stimulus. The large amounts of exogenous PGE1 in the present experiments may have potentiated this negative feedback effect, preventing LK production and the subsequent inflammatory effects, including the release of endogenous bone-resorbing PGs. Since PGE appears to inhibit lymphocyte activation through increasing intracellular cAMP (Bourne et al., 1974) , this probably accounts for the further prevention of the bone lesions when theophylline was administered with the PGE1.
Although pharmacological amounts of PGE 1 are required to suppress adjuvant arthritis, Zurier et al. (1973) suggested that in chronic disorders endogenous PGEs may build up to levels high enough to retard inflammation. While this is only a suggestion, we have indirect evidence that in the chronic phase of local tissue damage the anti-inflammatory activity of endogenous PGE prevails over its pro-inflammatory activity. Thus, PGE-precursor deprivation results in enhancement of the chronic phase of the adjuvant syndrome and increased tissue production in granulomata induced in rats , an effect which is accompanied by increased collagen synthesis (Pamham et al., 1977b) .
Although our results suggest that theophylline enhances the inhibitory effect of PGE1 through a cAMP-mediated mechanism, the details have yet to be elucidated. Because of the short biological halflife of exogenously administered PGs the possibility of PG-metabolite involvement has to be considered in interpreting our results. Thus, irrespective of whether given alone or in combination with theophylline, exogenous PGE1 may not have remained unmetabolised long enough to affect cellular infiltration and perhaps the ultimate effect was caused by a metabolite rather than by PGE ,. 
